Dorman Products (DORM) Reports In-Line Q1 EPS, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Dorman Products, Inc. Reports First Quarter 2021 Results
April 26, 2021 7:00 AM EDTHighlights:
Net sales of $288.0 million, up 12% as compared to $257.7 million in Q1 2020.Diluted earnings per share (EPS) of $1.02 up 46% as compared to $0.70 in Q1 2020.Adjusted diluted EPS* of $1.04, up 58% as compared to $0.66 in Q1 2020.Dormans strong balance sheet and ample liquidity provide solid foundation for growth.For fiscal 2021, the Company expects net sales growth between 9%-12%, diluted EPS of between $4.32 and $4.52, and adjusted diluted EPS*... More